chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am reporting the adverse event for a patient of mine who received the vaccine at a vaccination site at a local church:  The patient started having itching, redness and swelling at the vaccine site today.  This was likely a local reaction. The vaccine appears to have been given in an area of the arm that is much lower than the usual site.
Fever; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the left arm on 04Mar2021 at 12:45 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to Tegretol and pertussis. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included estradiol (MANUFACTURER UNKNOWN), finasteride (MANUFACTURER UNKNOWN), (LEXAPRO), buspirone (MANUFACTURER UNKNOWN) all for unknown indications and from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021 at 17:30, the patient experienced fever. It was unknown whether therapeutic measures were taken for the event fever. The clinical outcome of the event fever was not recovered at the time of reporting. Information about lot number cannot be obtained.   No further information is expected.
her arm where she had the vaccine is still sore and tingling; her arm where she had the vaccine is still sore and tingling; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration into the arm on Jan2021 at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient's arm where she had the vaccine was still sore and tingling on an unspecified date. Outcome of events was unknown.  Information about Lot/Batch number is requested.
About 4 hours after receiving the 2nd dose, my left arm started to become sore (where the shot was given) About 10 hours after receiving the 2nd dose, I started feeling "fluish" (achy, feverish, nauseous) All throughout that evening, the symptoms became worse and worse where I repeatedly took my temperature thinking I had a very high temperature only for it to read "below" normal at 97.3. The symptoms continued to get worse, without much sleep throughout the night and into the next day and evening.  I almost scheduled an appointment with my primary care physician on 4/24 because I felt so horrible.  It wasn't until about 11 am on the 2nd day  after receiving the shot (4/25) that I felt somewhat better and by that evening around 6pm, felt normal again. The 2nd dose was absolutely, without a doubt, MUCH worse of symptoms than the first dose. I hope this helps and please contact me with any questions or to help further.
Pt. inadvertently administered Pfizer monovalent formulation instead of bivalent at a community event. Pt. informed.
Area Lt deltoid, erythematous macular, red, painful, isolated/localized 2 inches in diameter, no fever, no drainage, no treatment.
Vagina Bleeding and cramping; Vagina Bleeding and cramping; This is a spontaneous report from a contactable consumer (patient). A 60-year-old non-pregnant female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6203, Expiry date: not reported, age at the time of vaccination: 60-year-old), via an unspecified route of administration, administered in Arm Right on 17Mar2021 08:15 as dose 2, single for covid-19 immunisation in facility. Medical history included High Blood Pressure, known allergies include Penicillin, Menopause (I have been post menopause for over 15 years.) Concomitant medication within 2 weeks included metoprolol succinate (TOPROL XL) at 50 mg. Previously the patient received first dose of bnt162b2 (Lot number EN6198), in Arm left on 25feb2021 12:00 for covid-19 immunization. On 17Mar2021 20:00, patient experienced vagina bleeding and cramping and the patient had received a treatment as she had contacted her physician. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with Covid-19, prior to vaccination and since the vaccination. The outcome of events was not recovered.
Pt has received anthrax vaccine Jan 2018, Jan 2020, and now Dec 2022.  One day letter urticaria developed across his body and he went to the urgent care 2 days after the vaccine was administered.  No anaphylaxis.  Pt has no history of food allergies, asthma, eczema etc.  No new foods introduced.  No medications other than Naproxen PRN which he had utilized for years.  No chronic conditions.  Pt is healthy and has a well documented medical record since he is tracked by clinic.
pt recv vax & exp itching & rash;pt also exp sl difficulty swallowing;
real drowsy; fatigued; talking and not making any sense/babble like talk; little weak; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 94 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 24Mar2021 14:30 (Batch/Lot number: unknown) at the age of 94 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "patient was up in age, and with her mind, was kind of losing it" (ongoing). The patient's concomitant medications were not reported. The following information was reported: SOMNOLENCE (non-serious) with onset 24Mar2021, outcome "recovering", described as "real drowsy"; FATIGUE (non-serious) with onset 24Mar2021, outcome "recovering", described as "fatigued"; SPEECH DISORDER (non-serious) with onset 24Mar2021, outcome "recovering", described as "talking and not making any sense/babble like talk"; ASTHENIA (non-serious) with onset Mar2021, outcome "recovering", described as "little weak".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sore tenderness under left armpit and left side of neck. General tiredness and lethargic, mild headache.
I received second shot on 17Apr2021 in left arm as first shot, today is 01Jul2021 and i am STILL HAVING SEVERE PAIN IN THE INJECTION ARM. I have responded to the messages I have received askin; This is a spontaneous report from a contactable consumer (patient) or other non hcp.   A 62 years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL3302, Expiration date: unknown), via an unspecified route of administration on 17Apr2021 (at the age of 61-year-old) as dose 2, single for covid-19 immunisation. Medical history included blood pressure abnormal. Concomitant medications included alprazolam (XANAX) taken for an unspecified indication, start and stop date were not reported, blood thinner (unspecified). The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL3302, Expiration date: unknown), via an unspecified route of administration on 27Mar2021 12:00PM as dose 1, single for covid-19 immunisation. The patient had no allergies.The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Apr2021 02:00, the patient experienced Pain in injection arm. Patient reported that he received second shot on 17apr2021 in left arm as first shot, today is 01jul2021 and he still have severe pain in the injection arm. The event resulted in doctor or other healthcare professional office/clinic visit. No treatment was taken as a result of event. The outcome of the event was not recovered.
Put down for nap and found by mother 1 hr later - face down. Pale, cold & non-responsive. CPR initiated. 911. Perfusing rhythm re-established in ED at 11:18. Never required any function. EEG - no electrical activity x 2. CT scan - compatible with hypoxic injury. Removed from life support on 7/31/11 at 14:40.
12pm Received shot 1 pm Sore arm at injection site  8pm loss of appetite, whole arm hurting  11pm fever 101, severe chills, body ache,  tiredness 11:30pm-3am fever 103.6, chills, body ache, tiredness, headache, confusion, sore on right side of body, high blood pressure161/96, high heart rate 120?s while resting, slighty sob (O2 low 90?s) slight chest pain on right side under Rib front and back, nausea, tingling lips for about 5 mins maybe.  12-30-20  3am still had fever 101 after taking Tylenol, blood pressure and heart rate decreased a little, chills stopped,  was able to sleep  7am  fever was 102 nausea headache sore right arm   Headache and Fever 102 continued all day, fever was a little lower taking Tylenol 12-31-20  Had headache/pressure in head all day temp 98.6-100 all day, felt a lot better, right arm still a little sore
arm still hurts; still a bit painful to try to reach behind my back; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm still hurts) and BACK PAIN (still a bit painful to try to reach behind my back) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (arm still hurts) and BACK PAIN (still a bit painful to try to reach behind my back). At the time of the report, VACCINATION SITE PAIN (arm still hurts) and BACK PAIN (still a bit painful to try to reach behind my back) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medicine, treatment and medical history were not provided by the reporter. Patient had difficulty in sleeping on his right side.
Received MMR and Varivax 10/19/04.  On 10/30/04 was seen in office with both erythematous, macular eruption to trunk and pruritic vesiculo-papular eruption to face, trunk and extremities.
Misread pts date of birth  on consent form , parent in room  did not indicate patient was minor.  I believed he was 18 yo . paperwork prepared by technician indicated jansen vaccine .  Gave patient the jansen vaccine and did not realize until further discussion with patient and parent after shot given date of birth was actually for 16 year old . I read a different dob, patient actual dob different.  Parent and patient not concerned not upset.   Discussed booster for patient should be a Pfizer dose.  Told parent we would follow up with them to make sure patient doing ok and parent was ok with that.
Pt received vaccine at about 12:15pm and was advised to stay in pharmacy to watch for any adverse reactions especially since it was patients first flu shot. After about 5 minutes pt started to experience vasovagal symptoms (paleness, sweating, fatigue). Pt was advised to sit down and onsite nurse was called to examine patient. Nurse was called and advised patient to lay down. Nurse began monitoring heart rate and blood pressure along with patients mental status. After about 90 minutes patients blood pressure and mental status were deemed ok by nurse but heart rate was abnormal ( at one time 120 bpm at others less than 60 bpm) Nurse advised patient to report to ED and released patient to wife. Patient informed nurse he would report to County for further observation)
Information has been received from a RN concerning a 67 year old retired male with sinusitis and no prior medical history who on 12/16/02 at 11:45 was vaccinated SC in the right arm with a second dose of pneumococcal vaccine 23 polyvalent (643783/0709M). Concomitant vaccination on 12/16/02 included a dose of influenza virus vaccine in the left arm. The pt was reported as afebrile at the time of the vaccination. There were no other concomitant medications. On 12/17/02 at 10:00, the pt developed increased warmth, edema, and erythema in his right upper arm. The pt was seen in the physician's office with fever of 100.6 F and localized swelling and redness at the injection site. The pt had full ROM in his hands and fingers bilaterally. It was also noted that there was no SOB and no wheezing for 2-3 days post vaccination. The pt was treatted with Clarinex 5mg daily as needed. Subsequently the pt recovered. Additional info is not expected.
Red, itchy, lumpy swelling (approximately 2" diameter), sore to the touch and to movement.  By day 9 (7/19) there is still a small lumpy area at the site of the injection.
7cm x 4cm red raised area at Varicella site. Rx = BENADRYL and H.C. Cream
My injection site was large and red afterward, but now that I am 12 days out from receiving the vaccine, the injection site looks horrible. It is a large red circle with a dark red rash around the circle.
Red, painful, hot to touch at injection site Rt arm. No tx for arthritic reaction.
Varicella like rash, slight itching (client on allergy medication).  Slight fever on 1st day.  53 spots total.  Spots concentrated on side of body that was nearest infected person.  Rash scabed over by 05/01/2003.
bud 1/7/23, vaccine administered 1/8/23. Moderna analysis found lot still active against covid-19 on date of administration
received only the liquid portion; received only the liquid portion; This case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a adolescent female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMCA602A, expiry date 31st August 2022) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate dose of vaccine administered and inappropriate preparation of medication. On an unknown date, the outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were unknown.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient was around 16 years of age. The patient might have received only the liquid portion of Menveo, which led to inappropriate dose of vaccine administered and inappropriate preparation of medication. The reporter consented to follow up. This case was 1 of 3 case reported by the reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021238417:same reporter US-GLAXOSMITHKLINE-US2021AMR238865:same reporter
Returned home at 11:30AM, uncontrollable crying and obvious pain. Gave Tylenol at 1:30pm to aid with pain. Temperature at 3:00pm was over 103F, crying and obvious pain, blue feet lips and consistent shaking. Called Dr. and reported to Hospital. Temperature at 104 and would not reduce with administration of Tylenol. Motrin given and fever still at 104. Released from hospital with 24 follow-up instructed.
chills with shaking; chills with shaking; joint pain; muscle pain; fatigue; swelling at injection site; pain at injection site; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EA9899, via an unspecified route of administration on Arm Left from 19Jan2021 08:15 to 19Jan2021 08:15 as single dose for COVID-19 immunisation. The patient took first dose of the BNT162B2 vaccine on an unspecified date. Medical history included asthma, penicillin (PCN) allergy, environmental allergies, and major depression. Concomitant medication included fluticasone propionate, salmeterol xinafoate (ADVAIR), montelukast sodium (SINGULAIR), fluoxetine hydrochloride (PROZAC), bupropion hydrochloride (WELLBUTRIN), and lamotrigine (LAMICTAL). On 19Jan2021 20:00, the patient experienced chills with shaking, joint pain, muscle pain, fatigue, swelling at injection site, and pain at injection site. The outcome of the events was recovering. Prior to vaccination and since the vaccination, was the patient was not diagnosed with COVID-19. No treatment was received for the events.
Right eye mattering, redness, and blurred vision. Bilateral rash on cheeks. Ocular symptom onset the morning after vaccination. Patient was sent with prescription for tobramycin 0.3% eye drops, to reserve for treatment if over-the-counter antihistamine and antihistamine eye drops were ineffective.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of  COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: The patient did not received other medication in 2weeks. Anti viral details included COVID 19 Treatment, Paxlovid started on 20Jan2023 to 24Jan2023 and lot number GF3904.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PARALYZING. EYES SWOLLEN. HANDS JOINTS ACHE.  LEGS FEEL LIKE CONCRETE.
Felt too hot after first  booster; Sore on & off for a long time after first; Weak Legs for 1-2 weeks post activity after first  booster; Feels weak for a while after a little house work after first  booster; Whiplash pain got worst after first  booster; Shoulders hurt just to walk after first  booster; Felt too tired after first  booster; This spontaneous case was reported by a patient and describes the occurrence of FEELING HOT (Felt too hot after first  booster), PAIN (Sore on & off for a long time after first ), MUSCULAR WEAKNESS (Weak Legs for 1-2 weeks post activity after first  booster), ASTHENIA (Feels weak for a while after a little house work after first  booster) and NECK PAIN (Whiplash pain got worst after first  booster) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A, 030A21A and 025B21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Whiplash injury in 1987. Concurrent medical conditions included Blood pressure high (controlled with medications).   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, the patient experienced FEELING HOT (Felt too hot after first  booster), PAIN (Sore on & off for a long time after first ), MUSCULAR WEAKNESS (Weak Legs for 1-2 weeks post activity after first  booster), ASTHENIA (Feels weak for a while after a little house work after first  booster), NECK PAIN (Whiplash pain got worst after first  booster), ARTHRALGIA (Shoulders hurt just to walk after first  booster) and FATIGUE (Felt too tired after first  booster). The patient was treated with KETOROLAC TROMETHAMINE (TORADOL) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING HOT (Felt too hot after first  booster), PAIN (Sore on & off for a long time after first ), MUSCULAR WEAKNESS (Weak Legs for 1-2 weeks post activity after first  booster), ASTHENIA (Feels weak for a while after a little house work after first  booster), NECK PAIN (Whiplash pain got worst after first  booster), ARTHRALGIA (Shoulders hurt just to walk after first  booster) and FATIGUE (Felt too tired after first  booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   One time the patient used the weed grabber.  The patient had high blood pressure which was controlled with medications but did not remember the name of BP medications.
died after getting one dose of the pfizer covid 19-vaccine; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age (reported as 57) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1 , single for COVID-19 immunisation. Medical history included overweight and diabetes, from an unknown date. The patient's concomitant medications were not reported. On an unspecified date, the patient died after getting one dose of the Pfizer COVID 19-vaccine, was not specific if it was due to the vaccine. The patient died on an unspecified date. Outcome of the event was fatal. It was not reported if an autopsy was performed.  Information on the lot/batch number has been requested.; Reported Cause(s) of Death: died after getting one dose of the pfizer covid 19-vaccine
Vaccination was improperly administered into shoulder rather than in upper arm. Injection administered one finger width below shoulder joint. At the time of administration, pain at site of injection. Worsening pain in left shoulder at vaccination site, radiating down outside of arm to wrist. Inflammation causing limited mobility in arm. Was seen at primary care physician's office for pain on 01/16/2013, was prescribed Motrin 600 mg 4 times/day and ice area.
Patient tested Positive for COVID-19 3/31/21. Patient received 1st dose of the COVID19 Pfizer Vaccine 12/20/20 - Lot EH9899 ; 2nd dose 1/10/21 Lot EK9231. Patient reported mild symptoms of congestion, cough, Sore throat and loss of smell for 2 day.
This spontaneous report as received from a physician refers to a 8 weeks old male patient with pertinent medical history of GERD and with no drug reactions/allergies. The patient was vaccinated with ROTATEQ (Lot# reported as 1807A17, orally, dose was unspecified) on 12-JUL-2012. No other co-suspects were reported. Concomitant medications included DTaP, IPV, PEDVAXHIB, PREVNAR 13, ZANTAC, deglycyrrhizinated licorice and PROBIOTICA. The physician stated the patient's parents reported the patient "turn extremely pale for 20-40 minutes three times in a 24 hour period" on 12-JUL-2012 after receiving ROTATEQ. The patient had sought medical attention via phone call. No lab diagnostics studies performed and no treatment was given for the adverse events. The outcome was reported as recovered/resolved (date unspecified). Additional information has been requested.